For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240926:nRSZ8010Fa&default-theme=true
RNS Number : 8010F SulNOx Group PLC 26 September 2024
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION
11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310
26 September 2024
SulNOx Group Plc (the "Company" or "SulNOx")
Granting of Share Options
Issue of Shares
(Aquis Stock Exchange: SNOX)
Granting of Share Options
The board of directors of the Company (the "Board") announces that it
yesterday granted share options to a director and certain employees and
consultants. Part of these options grants are under an Enterprise Management
Incentive scheme and part under an unapproved share option scheme. A total
of 980,000 options (the "Options") have been granted for ordinary shares of 2
pence each in the capital of the Company ("Ordinary Shares"), all with a
10-year life.
530,000 of the Options have been granted with an exercise price of 40.0p, a
small premium to the average closing price at which the Ordinary Shares traded
for the last five days of 37.7 pence. 250,000 of these Options vest
immediately, with the remainder subject to various vesting conditions.
250,000 of the Options have been granted with an exercise price of 36.0p,
under an existing contractual arrangement, which includes certain vesting
conditions. The remaining 200,000 Options have been granted with an exercise
price of 45.0p, all with vesting conditions.
Issue of Shares to Consultants
The Company has issued a total of 44,788 new Ordinary Shares in settlement of
invoices from consultants, made as follows:
· 20,979 Ordinary Shares at a price of 35.75 pence per Ordinary Share
in settlement of a liability of £7,500.00; and
· 23,809 Ordinary Shares at a price of 31.50 pence per Ordinary Share
in settlement of a liability of £7,500.00.
The prices of the above issues have been calculated on the average share price
for the period of time over which the services were delivered and the terms of
the consultants' contracts. An application will be made to admit the new
Ordinary Shares for trading on AQSE Growth Market, which is anticipated to
occur on or around 2 October 2024 ("Admission").
On Admission, the Company will have 121,550,946 Ordinary Shares in issue, each
with one voting right. The Company does not hold any shares in treasury and
therefore the total number of voting rights in the Company is 121,550,946.
This figure should be used by shareholders from Admission as the denominator
for the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in the Company under
the FCA's Disclosure Guidance and Transparency Rules.
- Ends -
For further information please contact:
SulNOx Group plc Tel: 07624 491 821
Steven Cowin, CFO
Allenby Capital Limited Tel: 020 3328 5656
(AQSE Corporate Adviser)
Nick Harriss / John Depasquale
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Alex Albertini
2 Reason for notification
a) Position / status NED
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name SulNOx Group plc
b) LEI 21380011EU95E93AQN91
4 Details of the transaction(s):
section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 2 pence each
Identification code
ISIN: GB00BJVQQP66
Nature of the transaction Grant of share options, subject to a market price of 50p at the time of
exercise
c) Price(s) and volumes(s) Price(s) Volume(s)
40p 250,000
d) Aggregated information N/A
Aggregated volume
Price
e) Date of the transaction 26 September 2024
f) Place of the transaction N/A
d)
Aggregated information
Aggregated volume
Price
N/A
e)
Date of the transaction
26 September 2024
f)
Place of the transaction
N/A
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NEXSEUSAMELSESU